Fortunes have been made on biotech stocks over the last few decades. The secret to success has been to invest in an up-and-coming biotech company before it even had a product on the market. Ideally, the company would have a pipeline featuring multiple promising candidates with significant commercial potential.

Viking Therapeutics (NASDAQ: VKTX) fits the profile of such a stock to a T. Could Viking be a millionaire-maker?

Many small biopharmaceutical companies are essentially one-trick ponies. They're betting the farm on a single pipeline candidate. Not Viking Therapeutics.

Continue reading

Source Fool.com